Progyny (PGNY) Stock Price

$21.44 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    5

  • Fundamental

    9

  • Technical

    5

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Progyny, AI stock picks, stock alerts and much more.

Sign up

PGNY AI Stock Analysis

AI stock analysis for PGNY is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Progyny (PGNY) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Progyny (PGNY) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Progyny (PGNY), currently trading at $21.44, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About PGNY

LSE

  • Progyny, Inc.

  • Symbol

    PGNY

  • Market

    NASDAQ

  • Industry

    Medical - Healthcare Information Services

  • Market Cap

    1.8B

Similar Stocks

GDRX GoodRx
GDRX		 $4.49
0.8%
4
GEHC GE HealthCare
GEHC		 $62.37
1.5%
5
SDGR Schrodinger
SDGR		 $25.75
2.1%
7
SPOK Spok
SPOK		 $15.67
1.7%
5
HCAT Health Catalyst
HCAT		 $3.84
2.4%
4

News

Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer

Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer
April 17, 2025. globenewswire.com
Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week®

Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week®
April 16, 2025. globenewswire.com
The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building

The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building
April 8, 2025. globenewswire.com
Progyny Expands Maternal Health Support with Addition of Doula Services

Progyny Expands Maternal Health Support with Addition of Doula Services
March 31, 2025. globenewswire.com

PGNY Alternative Data

Web Traffic

Progyny receives an estimated 246183 monthly visitors to progyny.com.

  • Web Traffic

    246183

  • Change from Previous Month

    8.3%

  • 3 Month Change

    7.3%

  • YoY Change

    7.3%

Reddit Mentions

Progyny has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

News Mentions

Progyny was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    100%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Twitter Followers

Progyny has 2,079 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.

  • Twitter Followers

    2079

  • Daily Change

    0%

  • 1 Month Change

    0.2%

  • 3 Month Change

    0.4%

Facebook Engagement

Progyny has engaged 56 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    56

  • Daily Change

    24.4%

  • 1 Month Change

    250%

  • 3 Month Change

    1300%

Instagram Followers

Progyny has 6,282 Instagram Followers on its main Instagram account, up by 4.9% over the last month.

  • Instagram Followers

    6282

  • Daily Change

    0.3%

  • 1 Month Change

    4.9%

  • 3 Month Change

    14.6%

Youtube Subscribers

Progyny has 10,100 subscribers on its main Youtube channel, up by 6.1% over the last month.

  • Youtube Subscribers

    10100

  • Daily Change

    0%

  • 1 Month Change

    6.1%

  • 3 Month Change

    20.7%

LinkedIn Followers

31,038 are following Progyny on LinkedIn, up by 3% over the last month.

  • LinkedIn Followers

    31038

  • Daily Change

    0.1%

  • 1 Month Change

    3%

  • 3 Month Change

    9.9%

App Downloads

  • App Downloads

    1984

  • Daily Change

    1.6%

  • 1 Month Change

    1.5%

  • 3 Month Change

    25.6%

Job Postings

Progyny has an estimated 33 open job postings, which is down -13.2% over the last month.

  • Job Postings

    33

  • Daily Change

    22.2%

  • 1 Month Change

    13.2%

  • 3 Month Change

    6.5%

LinkedIn Employees

According to LinkedIn, Progyny has 727 employees.

  • LinkedIn Employees

    727

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    6.3%

Business Outlook

According to employee reviews, the business outlook among employees at Progyny is 65 out of 100 (bullish).

  • Business Outlook

    65

  • Change from Previous Month

    15.6%

  • 3 Month Change

    0%

  • YoY Change

    0%

PGNY Financials

PGNY Key Metrics

  • Total Revenue

    $298.4M

  • Net Income

    $10.5M

  • Earnings per Share

    $0.12

  • Free cash flow

    $50.3M

  • EBITDA

    $15.8M

  • EBITDA Ratio

    0.0529

  • Total Assets

    $607.1M

PGNY 2-year Revenue & Income
PGNY 2-year Free Cash Flow

PGNY Technicals

PGNY SMA
PGNY RSI

FAQ

What's the current price of Progyny (PGNY) Stock?
The price of an Progyny (PGNY) share is $21.44.

What's the market cap of Progyny?
The current market cap of Progyny is 1.8B.

Should I buy or sell PGNY?
Progyny shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Progyny is better viewed as a hold or accumulate position while waiting for further developments.

Is Progyny a good investment?
The current analysis of Progyny's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Progyny's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Progyny (PGNY) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Progyny stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Progyny (PGNY) that investors often compare it to?
Progyny (PGNY) is often compared to similar stocks such as GoodRx, GE HealthCare, Schrodinger, Spok and Health Catalyst.

What is the forecast for Progyny's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Progyny's stock price to be around $21.95 in 2026. Starting from the current price of $21.44, this represents a 2.4% change in price, indicating a neutral outlook for the stock.

How to buy Progyny (PGNY) Stock?
Progyny stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Progyny shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.